16 research outputs found
Brain damage in methylmalonic aciduria: 2-methylcitrate induces cerebral ammonium accumulation and apoptosis in 3D organotypic brain cell cultures
ABSTRACT: BACKGROUND: Methylmalonic aciduria is an inborn error of metabolism characterized by accumulation of methylmalonate (MMA), propionate and 2-methylcitrate (2-MCA) in body fluids. Early diagnosis and current treatment strategies aimed at limiting the production of these metabolites are only partially effective in preventing neurological damage.
METHODS: To explore the metabolic consequences of methylmalonic aciduria on the brain, we used 3D organotypic brain cell cultures from rat embryos. We challenged the cultures at two different developmental stages with 1 mM MMA, propionate or 2-MCA applied 6 times every 12 h. In a dose--response experiment cultures were challenged with 0.01, 0.1, 0.33 and 1 mM 2-MCA. Immunohistochemical staining for different brain cell markers were used to assess cell viability, morphology and differentiation. Significant changes were validated by Western blot analysis. Biochemical markers were analyzed in culture media. Apoptosis was studied by immunofluorescence staining and Western blots for activated caspase-3.
RESULTS: Among the three metabolites tested, 2-MCA consistently produced the most pronounced effects. Exposure to 2-MCA caused morphological changes in neuronal and glial cells already at 0.01 mM. At the biochemical level the most striking result was a significant ammonium increase in culture media with a concomitant glutamine decrease. Dose--response studies showed significant and parallel changes of ammonium and glutamine starting from 0.1 mM 2-MCA. An increased apoptosis rate was observed by activation of caspase-3 after exposure to at least 0.1 mM 2-MCA.
CONCLUSION: Surprisingly, 2-MCA, and not MMA, seems to be the most toxic metabolite in our in vitro model leading to delayed axonal growth, apoptosis of glial cells and to unexpected ammonium increase. Morphological changes were already observed at 2-MCA concentrations as low as 0.01 mM. Increased apoptosis and ammonium accumulation started at 0.1 mM thus suggesting that ammonium accumulation is secondary to cell suffering and/or cell death. Local accumulation of ammonium in CNS, that may remain undetected in plasma and urine, may therefore play a key role in the neuropathogenesis of methylmalonic aciduria both during acute decompensations and in chronic phases. If confirmed in vivo, this finding might shift the current paradigm and result in novel therapeutic strategies
Ammonium accumulation is a primary effect of 2-methylcitrate exposure in an in vitro model for brain damage in methylmalonic aciduria.
Using 3D organotypic rat brain cell cultures in aggregates we recently identified 2-methylcitrate (2-MCA) as the main toxic metabolite for developing brain cells in methylmalonic aciduria. Exposure to 2-MCA triggered morphological changes and apoptosis of brain cells. This was accompanied by increased ammonium and decreased glutamine levels. However, the sequence and causal relationship between these phenomena remained unclear. To understand the sequence and time course of pathogenic events, we exposed 3D rat brain cell aggregates to different concentrations of 2-MCA (0.1, 0.33 and 1.0mM) from day in vitro (DIV) 11 to 14. Aggregates were harvested at different time points from DIV 12 to 19. We compared the effects of a single dose of 1mM 2-MCA administered on DIV 11 to the effects of repeated doses of 1mM 2-MCA. Pan-caspase inhibitors Z-VAD FMK or Q-VD-OPh were used to block apoptosis. Ammonium accumulation in the culture medium started within few hours after the first 2-MCA exposure. Morphological changes of the developing brain cells were already visible after 17h. The highest rate of cleaved caspase-3 was observed after 72h. A dose-response relationship was observed for all effects. Surprisingly, a single dose of 1mM 2-MCA was sufficient to induce all of the biochemical and morphological changes in this model. 2-MCA-induced ammonium accumulation and morphological changes were not prevented by concomitant treatment of the cultures with pan-caspase inhibitors Z-VAD FMK or Q-VD-OPh: ammonium increased rapidly after a single 1mM 2-MCA administration even after apoptosis blockade. We conclude that following exposure to 2-MCA, ammonium production in brain cell cultures is an early phenomenon, preceding cell degeneration and apoptosis, and may actually be the cause of the other changes observed. The fact that a single dose of 1mM 2-MCA is sufficient to induce deleterious effects over several days highlights the potential damaging effects of even short-lasting metabolic decompensations in children affected by methylmalonic aciduria
Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies.
Inherited peripheral neuropathies are a genetically heterogeneous group of disorders characterized by distal muscle weakness and sensory loss. Mutations in genes encoding aminoacyl-tRNA synthetases have been implicated in peripheral neuropathies, suggesting that these tRNA charging enzymes are uniquely important for the peripheral nerve. Recently, a mutation in histidyl-tRNA synthetase (HARS) was identified in a single patient with a late-onset, sensory-predominant peripheral neuropathy; however, the genetic evidence was lacking, making the significance of the finding unclear. Here, we present clinical, genetic, and functional data that implicate HARS mutations in inherited peripheral neuropathies. The associated phenotypic spectrum is broad and encompasses axonal and demyelinating motor and sensory neuropathies, including four young patients presenting with pure motor axonal neuropathy. Genome-wide linkage studies in combination with whole-exome and conventional sequencing revealed four distinct and previously unreported heterozygous HARS mutations segregating with autosomal dominant peripheral neuropathy in four unrelated families (p.Thr132Ile, p.Pro134His, p.Asp175Glu and p.Asp364Tyr). All mutations cause a loss of function in yeast complementation assays, and p.Asp364Tyr is dominantly neurotoxic in a Caenorhabditis elegans model. This study demonstrates the role of HARS mutations in peripheral neuropathy and expands the genetic and clinical spectrum of aminoacyl-tRNA synthetase-related human disease
Genome-Wide Linkage in a Highly Consanguineous Pedigree Reveals Two Novel Loci on Chromosome 7 for Non-Syndromic Familial Premature Ovarian Failure
BACKGROUND: The human condition known as Premature Ovarian Failure (POF) is characterized by loss of ovarian function before the age of 40. A majority of POF cases are sporadic, but 10-15% are familial, suggesting a genetic origin of the disease. Although several causal mutations have been identified, the etiology of POF is still unknown for about 90% of the patients.¦METHODOLOGY/PRINCIPAL FINDINGS: We report a genome-wide linkage and homozygosity analysis in one large consanguineous Middle-Eastern POF-affected family presenting an autosomal recessive pattern of inheritance. We identified two regions with a LOD(max) of 3.26 on chromosome 7p21.1-15.3 and 7q21.3-22.2, which are supported as candidate regions by homozygosity mapping. Sequencing of the coding exons and known regulatory sequences of three candidate genes (DLX5, DLX6 and DSS1) included within the largest region did not reveal any causal mutations.¦CONCLUSIONS/SIGNIFICANCE: We detect two novel POF-associated loci on human chromosome 7, opening the way to the identification of new genes involved in the control of ovarian development and function
Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines
Altered expression and posttranslational modification of neurofilaments in methylmalonic aciduria
Neurofilaments (NF), the main components of axonal cytoskeleton, are known
to be involved in several neurodegenerative diseases. It has been reported that
methylmalonate and propionate affect phosphorylation of NFs. In an in vitro
model for methylmalonic aciduria our group has recently shown that 2-
methylcitrate (2-MCA) is the most toxic metabolite for developing brain cells.
Here, we studied the effects of repetitive administration of 1mM 2-
MCA every 12 hours over 3 days on the development of NFs in 3D
organotypic rat brain cell cultures.
By immunohistochemistry with antibodies specific for the different NF
subunits (light NFL, medium NFM, heavy NFH) as well as for phosphorylated
(p) and glycosylated (g) forms of NFs, we observed a
decrease of axonal labeling and a disorganized axonal pattern. Interestingly,
signal retention of p-NFM and g-NFM was observed in neuronal
soma. Western blotting showed the decrease of NFL and NFH
subunits.
Taken together, our data show that 2-MCA alters expression of the different
NF subunits as well as their post-translational modifications. This likely
results in disturbed NF assembly, abnormal accumulation of NF in neuronal
cell bodies and impairment of axonal development.We conclude thatNF are
involved in 2-MCA-induced neurodegeneration in methylmalonic aciduria
Low concentrations of 3-hydroxy glutarate leads to ammonium accumulation and non-apoptotic cell death in developing brain cells
We previously showed in a 3D rat brain cell in vitro model for glutaric
aciduria type-I that repeated application of 1mM 3-hydroxy-glutarate
(3-OHGA) caused ammonium accumulation, morphologic alterations
and induction of non-apoptotic cell death in developing brain cells.
Here, we performed a dose-response study with lower concentrations of 3-
OHGA.We exposed our cultures to 0.1, 0.33 and 1mM 3-OHGA every 12h
over three days at two developmental stages (DIV5-8 and DIV11-14).
Ammonium accumulation was observed at both stages starting from
0.1mM 3-OHGA, in parallel with a glutamine decrease. Morphological
changes started at 0.33mM with loss of MBP expression and loss of
astrocytic processes. Neurons were not substantially affected. At DIV8,
release of LDH in the medium and cellular TUNEL staining increased
from 0.1mM and 0.33mM 3-OHGA exposure, respectively. No increase
in activated caspase-3 was observed.
We confirmed ammonium accumulation and non-apoptotic cell
death of brain cells in our in vitro model at lower 3-OHGA
concentrations thus strongly suggesting that the observed effects
are likely to take place in the brain of affected patients. The
concomitant glutamine decrease suggests a defect in the astrocyte
ammonium buffering system. Ammonium accumulation might be
the cause of non-apoptotic cell death
BRAIN DAMAGE IN METHYLMALONIC ACIDURIA: 2-METHYLCITRATE LEADS TO AMMONIA INCREASE AND APOPTOSIS
A 3D in vitro model of rat organotypic brain cell cultures in aggregates was
used to investigate neurotoxicity mechanisms in methylmalonic aciduria.
1 mM methylmalonate (MMA), 2-methylcitrate (2-MCA) or propionate
(PA) were repeatedly added to the culture media at two different time points
of the cultures. In cultures treated with 2-MCA, we observed a significant
increase of lactate in the medium, consistent with a possible inhibition of
Krebs cycle and respiratory chain, as described earlier in the literature.
Interestingly, we further observed that 2-MCA induced an important increase
in ammonia production with concomitant decrease of glutamine
concentrations, which suggests an inhibition of the astrocytic enzyme
glutamine synthetase. These previously unreported findings may uncover
a pathogenic mechanism in this disease with deleterious effects on early
stages of brain development. By immunohistochemistry we could show that
2-MCA substantially increased the number of apoptotic cells. On the
cellular level, 2-MCA had a toxic effect (cell swelling and cell death) on
glial cells, but not on neurons. Surprisingly, MMA seemed to have a growth
stimulating effect on the cultures. We can conclude that 2-MCA was the
most toxic metabolite in our model for methylmalonic aciduria inducing
ammonia accumulation and massive apoptosis in brain cells
NEUROPATHOPHYSIOLOGICAL MECHANISMS IN GLUTARIC ACIDURIA TYPE I: 3-HYDROXYGLUTARIC ACID LEADS TO AMMONIA INCREASE AND NON-APOPTOTIC CELL DEATH
A 3D in vitro model of rat organotypic brain cell cultures in aggregates was
used to investigate neurotoxicity mechanisms in glutaric aciduria type I
(GA-I). 1 mM glutarate (GA) or 3-hydroxyglutarate (3OHGA) were repeatedly
added to the culture media at two different time points. In cultures
treated with 3OHGA, we observed an increase in lactate in the medium,
pointing to a possible inhibition of Krebs cycle and respiratory chain. We
further observed that 3OHGA and to a lesser extend GA induced an
increase in ammonia production with concomitant decrease of glutamine
concentrations, which may suggest an inhibition of the astrocytic enzyme
glutamine synthetase. These previously unreported findings may uncover a
pathogenic mechanism in this disease which has deleterious effects on early
stages of brain development. By immunohistochemistry we showed that
3OHGA increased non-apoptotic cell death. On the cellular level, 3OHGA
and to a lesser extend GA led to cell swelling and loss of astrocytic fibers
whereas a loss of oligodendrocytes was only observed for 3OHGA. We
conclude that 3OHGAwas the most toxic metabolite in our model for GA-I.
3OHGA induced deleterious effects on glial cells, an increase of ammonia
production, and resulted in accentuated cell death of non-apoptotic origin
Different types of cell death are involved in brain damage of methylmalonic aciduria and glutaric aciduria type I
We previously showed that exposure of 3D organotypic rat brain cell
cultures to 1mM 2-methylcitrate (2-MCA) or 3-hydroxyglutarate (3-
OHGA) every 12h over three days (DIV11-DIV14) results in ammonium
accumulation and cell death. The aim of this study was to define the
time course (every 24h) of the observed effects.
Ammonium in culture medium already increased at DIV12 staying
stable on the following days under 3-OHGA exposure, while it increased
consecutively up to much higher levels under 2-MCA
exposure. Lactate increase and glucose decrease were observed from
DIV13 and DIV14, respectively. We conclude that ammonium accumulation
precedes alterations of energy metabolism.
As observed by immunohistochemistry glial cells were the predominant
dying cells. Immunoblotting and immunohistochemistry with cell death
specific markers (caspase-3, alpha-fodrin, LC3) showed that 2-MCA
exposure significantly increased apoptosis on DIV14, but did not alter
autophagy or necrosis. In contrast, 3-OHGA exposure substantially
increased necrosis already from DIV13, while no change was observed
for apoptosis and autophagy.
In conclusion, ammonium accumulation, secondary disturbance of energy
metabolism and glial cell death are involved in the neuropathogenesis
ofmethylmalonic aciduria and glutaric aciduria type I. Interestingly, brain
cells are dying by necrosis under 3-OHGA exposure and by apoptosis
under 2-MCA exposure